Evidence map›Paper›PMID 31259033›Full record

ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2019

A Domain Knowledge-Enhanced LSTM-CRF Model for Disease Named Entity Recognition.

Yuan Ling, Sadid A Hasan, Oladimeji Farri, Zheng Chen, Rob van Ommering, Charles Yee, Nevenka Dimitrova

Abstract read
In one paragraph

Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuan LingPhilips Research North America, Cambridge, MA, USA.
Sadid A HasanPhilips Research North America, Cambridge, MA, USA.
Oladimeji FarriPhilips Research North America, Cambridge, MA, USA.
Zheng ChenPhilips Research North America, Cambridge, MA, USA.
Rob van OmmeringPhilips Research North America, Cambridge, MA, USA.
Charles YeePhilips Research North America, Cambridge, MA, USA.
Nevenka DimitrovaPhilips Research North America, Cambridge, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disease named entity recognition (NER) is a critical task for most biomedical natural language processing (NLP) applications. For example, extracting diseases from clinical trial text can be helpful for patient profiling and other downstream applications such as matching clinical trials to eligible patients. Similarly, disease annotation in biomedical articles can help information search engines to accurately index them such that clinicians can easily find relevant articles to enhance their knowledge. In this paper, we propose a domain knowledge-enhanced long short-term memory network-conditional random field (LSTM-CRF) model for disease named entity recognition, which also augments a character-level convolutional neural network (CNN) and a character-level LSTM network for input embedding. Experimental results on a scientific article dataset show the effectiveness of our proposed models compared to state-of-the-art methods in disease recognition.

Identifiers

PMID31259033
PMCPMC6568095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.